Press Release|

SHL expands in Taiwan with 800 new jobs

In January, SHL Group announced plans to create 800 new jobs in Taiwan to support ramped up productions for SHL Medical. SHL Medical is SHL Group’s largest group company offering comprehensive solutions for advanced drug delivery devices to the global pharmaceutical and biopharmaceutical industry.

The ramp-up reflects a growing demand for injectable devices as well as SHL’s commitment to meeting those demands. “For the past 30 years, SHL has always pushed to provide our customers with the best solutions to support their innovative drugs. Our focus on quality has contributed to our growth, which has in turn led to our need to recruit more talents to the SHL family,” said Ulrich Faessler, CEO of SHL Medical.

SHL has since recruited 50% of the additional positions, which it expects to fill by the end of the third quarter. The additional labor force will work among SHL’s TY1, TY2, NK, and Liufu facilities, which are all located within Taoyuan City.

Director of Human Resources Lillian Yao said, “Taiwan is recognized globally for its innovative environment and top-quality labor force. These circumstances, along with substantial support from both the government and the community, have enabled us to become a leader of advanced drug delivery systems.”

SHL Group celebrates its 30th anniversary this year. With this expansion, SHL Group will have more than 4,500 employees in Taiwan and over 5,000 employees globally.

About SHL

SHL Group is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

 

Share:

Related News